Home

Sun Pharmaceuticals Industries Ltd PE Ratio

Image

Sun Pharmaceuticals Industries Ltd

NSE: SUNPHARMA

PE

38.2

Last updated on: Jan 12, 2025

Key Highlights

  • The P/E Ratio of Sun Pharmaceuticals Industries Ltd is 38.2 as of 12 Jan 9.00 AM .
  • The P/E Ratio of Sun Pharmaceuticals Industries Ltd changed from 22.5 on March 2020 to 40.6 on March 2024 . This represents a CAGR of 12.53% over 5 years.
  • The Latest Trading Price of Sun Pharmaceuticals Industries Ltd is ₹ 1786 as of 10 Jan 15:30 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 21.0 to 40.0 in 5 years. This represents a CAGR of 13.75%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.4. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.6. The PE Ratio of Textiles industry is 36.9 in 2024.

Historical P/E Ratio of Sun Pharmaceuticals Industries Ltd

No data available

Company Fundamentals for Sun Pharmaceuticals Industries Ltd

Image

Sun Pharmaceuticals Industries Ltd

NSE: SUNPHARMA

Share Price

₹ 1786.05

-40.05 (-2.19%)

stock direction

Last updated on: Jan 10, 2025

Market Price of Sun Pharmaceuticals Industries Ltd

1M

1Y

3Y

5Y

Monitoring Sun Pharmaceuticals Industries Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
10 Jan 20251786.05
09 Jan 20251826.1
08 Jan 20251837.3
07 Jan 20251854.15
06 Jan 20251846.95
03 Jan 20251849.1
02 Jan 20251878
01 Jan 20251889.8
31 Dec 20241884.5
30 Dec 20241882.2

SWOT Analysis Of Sun Pharmaceuticals Industries Ltd

Strength

2

che

Weakness

2

che

Opportunity

0

che

Threats

1

che

BlinkX Score for Sun Pharmaceuticals Industries Ltd

Asset Value vs Market Value of Sun Pharmaceuticals Industries Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Competitive Comparison of P/E Ratio

Company
leftMarket Capright
Sun Pharmaceuticals Industries Ltd428533
Divis Laboratories Ltd153076
Cipla Ltd118723
Dr Reddys Laboratories Ltd112998
Mankind Pharma Ltd112971

PE Ratio of Sun Pharmaceuticals Industries Ltd Explained

``

428533

Market cap

11054

Earnings

38.2X

PE Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Sun Pharmaceuticals Industries Ltd

No data available

* All values are in crore

Historical Revenue, EBITDA and Net Profit of Sun Pharmaceuticals Industries Ltd

Revenue

EBITDA

Net Profit

No data available

* All values are in crore

Historical Dividend Payout of Sun Pharmaceuticals Industries Ltd

No data available

* All values are in %

About Sun Pharmaceuticals Industries Ltd

  • Sun Pharmaceutical Industries Limited including its subsidiaries and associates (Sun Pharma) is the fourth largest global specialty generic company that is ranked No. 1 in India and No. 8 in the US. It is the largest Indian pharmaceutical company in the US and among the leading Indian pharmaceutical companies in emerging markets.
  • The company manufactures and markets a large basket of pharmaceutical formulations covering a broad spectrum of chronic and acute therapies.
  • It includes generics, branded generics, complex or difficult to make technology intensive products, over-the-counter (OTC) products, anti-retrovirals (ARVs), Active Pharmaceutical Ingredients (APIs) and intermediates.
  • The product portfolio of over 2000 high quality molecules covers multiple dosage forms, including tablets, capsules, injectables, sprays, inhalers, drug delivery systems, ointments, creams and liquids.

Sun Pharmaceuticals Industries Ltd News Hub

Sun Pharmaceuticals Industries Ltd spurts 0.31%, up for fifth straight session

Sun Pharmaceuticals Industries Ltd gained for a fifth straight session today. The stock is quoting a

Read more

2024-08-20 00:00:00

Sun Pharmaceutical to invest USD 15 mn in Pharmazz Inc.

Sun Pharmaceutical Industries has entered into an agreement with Pharmazz Inc. Delaware US, pursuant

Read more

2024-08-14 00:00:00

Sun Pharma Q1 PAT climbs 40% YoY to Rs 2,835 cr

Profit before tax was at Rs 3,423.5 crore in Q1 FY25, registering a growth of 37.98% on YoY basis. D

Read more

2024-08-01 00:00:00

Sun Pharmaceuticals Industries consolidated net profit rises 40.20% in the June 2024 quarter

Net profit of Sun Pharmaceuticals Industries rose 40.20% to Rs 2835.62 crore in the quarter ended Ju

Read more

2024-08-01 00:00:00

Product Composition by Percentage (Revenue)

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Sun Pharmaceuticals Industries Ltd

What is the current PE Ratio of Sun Pharmaceuticals Industries Ltd?

The Current PE Ratio of Sun Pharmaceuticals Industries Ltd is 38.23 as on 12 Jan 2025.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 12 Jan 2025.

What was the PE Ratio of Sun Pharmaceuticals Industries Ltd last year?

The PE Ratio of Sun Pharmaceuticals Industries Ltd was 27.83 last year, now the PE ratio is 38.23, showing a year-on-year growth of 37.4%.

What does the PE Ratio of Sun Pharmaceuticals Industries Ltd indicate about its stock?

The PE Ratio of Sun Pharmaceuticals Industries Ltd is 38.23. This ratio indicates that investors are willing to pay 38.23 times the earnings per share for each share of Sun Pharmaceuticals Industries Ltd.

What is the PE Ratio Growth of Sun Pharmaceuticals Industries Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Sun Pharmaceuticals Industries Ltd grew by 37.4% whereas, the EPS ratio grew by 7.6.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions